Skip to content

HYPNotherapy for improving distress and sleep in Adolescents and Young Adults with cancer: a feasibility study

HYPNotherapy for improving distress and sleep in Adolescents and Young Adults with cancer: a feasibility study - HYPNAYA feasibility study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON53319
Enrollment
30
Registered
2023-06-14
Start date
2023-07-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Distress fear

Interventions

Hypnotherapy The hypnotherapy will include 2 individual hypnotherapy sessions plus daily listening to these recorded sessions and to (3 or 4) standardized hypnosis recordings. The individual session

Sponsors

Amsterdam UMC
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Consecutive AYAs (age 18-39) at the (outpatient) clinic that are actively being treated for cancer.

Exclusion criteria

Exclusion criteria: Patients already being treated for psychiatric illness will be excluded.

Design outcomes

Primary

MeasureTime frame
The primary outcome is feasibility of hypnotherapy as supportive treatment for AYA patients defined as the proportion of patients that complete the 8 weeks of treatment. Complete is defined as attending both individual hypnotherapy sessions.

Secondary

MeasureTime frame
Secondary outcome measures : - Feasibility of included questionnaires measured by the proportion of patients that complete all questionnaires pre-intervention (T0) and post-intervention (T3 and T4). - Feasibility of self-hypnosis measured by the proportion of patients that weekly perform self-hypnosis exercises and use recorded scripts for self-hypnosis measured using a structured exit interview on the experiences with medical hypnotherapy. - Patient-reported satisfaction measured using a structured exit interview on the experiences with medical hypnotherapy. - Reach measured as the number of participants and non-participants from the eligible patient population. Both numbers are retrieved from the central study database completed by the study coordinator. - Distress (i.e. anxiety and depression) measured using the Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety (7a) and Depression (8a) questionnaire. - Fear of cancer progression as assessed using the Cancer Worry Scale (CWS) questionnaire. - Quality of sleep as assessed by the Pittsburgh Sleep Quality Index (PSQI) questionnaire. - Quality of life as assessed using the QLQ-C30 (version 3.0) questionnaire. - Change in distress, fear of cancer progression, quality of sleep and quality of life measured by comparing outcomes of questionnaires pre-intervention (T0) and post-intervention (T3). - Exploration of domains in which AYAs find positive emotions and energy, exploration of coping strategies and exploration of domains with unmet needs.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jul 3, 2026